Kornitzer Capital Management Inc. KS increased its stake in SunOpta, Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 21.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 252,700 shares of the company's stock after purchasing an additional 44,700 shares during the quarter. Kornitzer Capital Management Inc. KS owned approximately 0.21% of SunOpta worth $1,228,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of STKL. Granahan Investment Management LLC grew its stake in SunOpta by 26.9% during the 4th quarter. Granahan Investment Management LLC now owns 2,782,215 shares of the company's stock valued at $21,423,000 after acquiring an additional 589,485 shares in the last quarter. Franklin Resources Inc. grew its stake in SunOpta by 1,015.0% during the 4th quarter. Franklin Resources Inc. now owns 587,749 shares of the company's stock valued at $4,526,000 after acquiring an additional 535,034 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in SunOpta during the 4th quarter valued at about $4,027,000. Portolan Capital Management LLC grew its stake in SunOpta by 32.8% during the 4th quarter. Portolan Capital Management LLC now owns 1,667,498 shares of the company's stock valued at $12,840,000 after acquiring an additional 411,567 shares in the last quarter. Finally, Woodline Partners LP grew its stake in SunOpta by 26.2% during the 4th quarter. Woodline Partners LP now owns 1,541,019 shares of the company's stock valued at $11,866,000 after acquiring an additional 320,284 shares in the last quarter. Hedge funds and other institutional investors own 85.39% of the company's stock.
Insiders Place Their Bets
In other SunOpta news, CEO Brian W. Kocher purchased 10,000 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was bought at an average cost of $5.72 per share, for a total transaction of $57,200.00. Following the completion of the acquisition, the chief executive officer directly owned 10,000 shares in the company, valued at $57,200. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.90% of the company's stock.
SunOpta Stock Performance
Shares of NASDAQ STKL remained flat at $6.29 during trading hours on Friday. The company had a trading volume of 617,001 shares, compared to its average volume of 808,702. The firm has a market capitalization of $739.34 million, a P/E ratio of -48.38 and a beta of 1.43. The company's 50 day moving average price is $6.05 and its 200-day moving average price is $5.98. SunOpta, Inc. has a 1-year low of $3.65 and a 1-year high of $8.11. The company has a quick ratio of 0.43, a current ratio of 0.95 and a debt-to-equity ratio of 1.50.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.02 by $0.02. SunOpta had a positive return on equity of 11.65% and a negative net margin of 1.90%. The business had revenue of $201.63 million during the quarter, compared to analysts' expectations of $195.09 million. As a group, analysts expect that SunOpta, Inc. will post 0.13 EPS for the current fiscal year.
SunOpta Company Profile
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Recommended Stories

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.